Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.

Topline: Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker ...

Nationally, about 208 Black men per 100,000 died from cancer, as opposed to 179 per 100,000 white men, the study said. About ...

Researchers from Rice University and Vanderbilt University have made significant advancements in the fight against prostate ...

Cancer deaths among Black men and women in the United States have declined during the past decade in the United States, a new American Cancer Society report says.

The FDA has granted fast track status to 67Cu-SAR-bisPSMA for metastatic prostate cancer that is resistant to hormone therapy ...

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

An analysis of prostate cancer trends in California revealed an unexpected spike in distant-stage disease cases between 2011 and 2021.Meanwhile, prostate cancer mortality — which had been on the ...

Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...

A new report shows while cancer death rates among Black people are declining, they remain higher than other racial and ethnic ...

Since 2019, the Hawks and PCF have partnered together to combat prostate cancer and raise awareness about the disease. Last ...

The company, now based in North Beach, has lost more than $2 billion over 29 years. Its only approved drug, called roxadustat ...